Where Ventyx Biosciences Stands With Analysts
Portfolio Pulse from Benzinga Insights
Ventyx Biosciences (NASDAQ:VTYX) has received positive analyst ratings in the last quarter, with 2 bullish and 3 somewhat bullish ratings. The average 12-month price target for the company is $58.6, a 0.6% increase from the previous average of $58.25.
August 11, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ventyx Biosciences has received positive analyst ratings, which could potentially boost its stock price.
Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, Ventyx Biosciences has received predominantly positive ratings, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100